Daconib 45 mg (Dacomitinib) | Online International Pharmacy Daconib 45 mg (Dacomitinib) is a targeted therapy used to treat non-small cell lung cancer with specific EGFR gene mutations.

Daconib 45 mg (Dacomitinib) is an oral tyrosine kinase inhibitor used for the treatment of metastatic non-small cell lung cancer (NSCLC) with EGFR gene mutations, helping block cancer cell growth and spread.
#Daconib45mg #Dacomitinib #OnlineMedicine #Oncology #Health
jnspharma.com/product/daco...